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(Fig. 1). The patient was admitted for further investigation.A number of studies have demonstrated that Riata familyA 51 year old man with arrhythmogenic right ventricular
cardiomyopathy reported non-specific symptoms of muscle
aches and shivering at outpatient review. A dual chamber
implantable cardioverter defibrillator (ICD) had been inserted
seven years previously. Fluoroscopic lead screening had pre-
viously demonstrated conductor externalisation (Figure and
Video) of a single coil Riata ICD lead (model number 1582-65,
St. Jude Medical, Sylmar, CA, USA). All electrical parameters
were normal.
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.ipej.2015.07.014.
A transoesophageal echocardiogram (TOE) with ultrasound
contrast revealed a well circumscribed, 1 cm diameter, echo-l Victoria Hospital, Gr
.com (N.A. McKeag).
eart Rhythm Society.
ythm Society. Production
mons.org/licenses/by-ncClinical examination was unremarkable. Investigations
revealed a normal full blood count, electrolyte profile,
C-reactive protein concentration and erythrocyte sedimenta-
tion rate. Multiple blood cultures were sterile. The echocar-
diographic findings and clinical picture were felt to be in
keeping with thrombus formation and the patient was anti-
coagulated with warfarin. A repeat TOE after 3 months of
warfarin therapy revealed complete resolution of the right
atrial mass.
ICD leads are at greater risk of insulation breach resulting in
conductor externalization [1]. The optimal management of
patients with a Riata lead is unclear. The U.S. Food and Drug
Administration has recommended that lead replacement
should be considered in patients with a Riata lead with evi-
dence of conductor externalization and abnormal electrical
parameters [2]. We believe that thrombus formation in the
present case was related to conductor externalization. A small
number of similar cases have been described previously [3].
Thrombus formationwith the risk of pulmonary embolism is a
serious complication of Riata lead conductor externalization. If
the lead remains in place, lifelong anticoagulation and careful
serial echocardiographic monitoring is indicated. Thrombus
formationmay be asymptomatic orminimally symptomatic as
in this case. If a significant degree of conductor externalization
is noted during fluoroscopic screening, consideration shouldosvenor Road, Belfast BT12 6BA, UK. Tel.: þ447843667469;
and hosting by Elsevier B.V. This is an open access article under
-nd/4.0/).
Fig. 1 e Panel A: Fluoroscopic image demonstrating conductor externalisation (arrow) affecting the implantable cardioverter
defibrillator (ICD) lead. Panel B: Contrast transoesophageal echocardiogram image demonstrating a 1 cm mass in the right
atrium (arrow) associated with the ICD lead.
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exclude thrombus formation.
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